Biomarkers of drug-induced skeletal muscle injury in the rat: Troponin I and myoglobin

Toxicological Sciences

Volumn 111, Issue 2, 2009, Pages 402-412

  Vassallo, Jeffrey D ^a,b   Janovitz, Evan B ^a   Wescott, Debra M ^a   Chadwick, Chris ^c   Lowe Krentz, Linda J ^b   Lehman Mckeeman, Lois D ^a  

^a BRISTOL MYERS SQUIBB   (United States)

^b LEHIGH UNIVERSITY   (United States)

^c Life Diagnostics Inc   (United States)

Author keywords

Biomarkers; Cerivastatin; Cobalt; Coumarin; Isoproterenol; Myoglobin; Myopathy; Rat; Skeletal muscle; Triamcinolone; Troponin I

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; BMS 600149; BMS 687453; CERIVASTATIN; COUMARIN; CREATINE KINASE; FRUCTOSE BISPHOSPHATE ALDOLASE; ISOPRENALINE; MYOGLOBIN; TOXIC SUBSTANCE; TRIAMCINOLONE ACETONIDE; TROPONIN I; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; CELL INFILTRATION; CELL VACUOLE; CONTROLLED STUDY; CREATININE URINE LEVEL; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; LIPIDOSIS; LIVER NECROSIS; LIVER TOXICITY; MALE; MUSCLE ATROPHY; MUSCLE INJURY; MYOPATHY; NONHUMAN; PROTEIN BLOOD LEVEL; RAT; SPRAGUE DAWLEY RAT;

AMINO ACID SEQUENCE; ANIMALS; BIOLOGICAL MARKERS; FEMALE; MALE; MOLECULAR SEQUENCE DATA; MUSCLE, SKELETAL; MYOGLOBIN; RATS; RATS, SPRAGUE-DAWLEY; TROPONIN I;

RATTUS;

EID: 70349281882     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfp166     Document Type: Article

References (34)

1. Ariano, M. A., Armstrong, R. B., and Edgerton, V. R. (1973). Hindlimb muscle fiber populations of five mammals. J. Histochem. Cytochem. 21, 51-55.
2. Babuin, L., and Jaffe, A. S. (2005). Troponin: The biomarker of choice for the detection of cardiac injury. CMAJ 173, 1191-1202.
3. Bender, H. S. (2003). Muscle. In Veterinary Laboratory Medicine: Clinical Pathology, 4th edn. (K. S. Latimer, E. A. Mahaffey, and K. W. Prasse, Eds.), pp. 260-269. Iowa State University Press, Ames, IA.
4. Bohlmeyer, T. J., Wu, A. H. B., and Perryman, M. B. (1994). Evaluation of laboratory tests as a guide to diagnosis and therapy of myositis. Rheum. Dis. Clin. North Am. 20, 845-856.
5. Braunstein, P. W., and De Girolami, U. (1981). Experimental corticosteroid myopathy. Acta Neuropathol. 55, 167-172.
6. De Souza, A., Cornwell, P., Dai, X., Caguyong, J., and Ulrich, R. (2006). Agonists of the peroxisome proliferator-activated receptor alpha induce a fiber-type-selective transcriptional response in rat skeletal muscle. Toxicol. Sci. 92, 578-586.
7. Goodsaid, F. M., Frueh, F. W., and Mattes, W. (2008). Strategic paths for biomarker qualification. Toxicology 245, 219-223.
8. Gordon, A. M., Homsher, E., and Regnier, M. (2000). Regulation of contraction in striated muscle. Physiol. Rev. 80, 853-924.
9. Hamalainen, N., and Pette, D. (1993). The histochemical profiles of fast fiber types IIB, IID and IIA in skeletal muscles of mouse, rat and rabbit. J. Histochem. Cytochem. 41, 733-743.
10. Hoffmann, W. E., Wilson, B. W., and Solter, P. F. (1999). Clinical enzymology. In The Clinical Chemistry of Laboratory Animals, 2nd edn. (W. F. Loeb and F. W. Quimby, Eds.), pp. 399-454. Taylor and Francis, Philadelphia, PA.
11. Knapton, A. D., Espandiari, P., Morales, A., Moussazadeh, M., Robins, T., and Herman, E. (2008). The utility of monitoring skeletal muscle troponin I to detect drug-induced skeletal muscle injury. FASEB J. 22, 11.
12. Koerker, D. J., Sweet, I. R., and Baskin, D. G. (1990). Insulin binding to individual rat skeletal muscles. Endocrinol. Metab. 22, E517-E523.
13. Koppe, R. I., Hallauer, P. L., Karpati, G., and Hastings, K. E. M. (1989). cDNA clone and expression analysis of rodent fast and slow skeletal muscle troponin I mRNAs. J. Biol. Chem. 264, 14327-14333.
14. Kumagai, M., Kondo, T., Ohta, Y., and Ishihara, T. (2001). Size and composition changes in diaphragmatic fibers in rats exposed to chronic hypercapnia. Chest. 119, 565-571.
15. Lake, B. G. (1999). Coumarin metabolism, toxicity and carcinogenicity: Relevance for human risk assessment. Food Chem. Toxicol. 37, 423-453.
16. Lee, M. C., Wee, G. R., and Kim, J. H. (2005). Apoptosis of skeletal muscle on steroid-induced myopathy in rats. J. Nutr. 135, 1806S-1808S.
17. Mukherjee, R., Locke, K. T., Miao, B., Meyers, D., Monshizadegan, H., Zhang, R., Search, D., Grimm, D., Flynn, M., O'Malley, K. M., et al. (2008). Novel peroxisome proliferator-activated receptor alpha agonists lower low-density lipoprotein and triglycerides, raise high-density lipoprotein, and synergistically increase cholesterol excretion with a liver X receptor agonist. J. Pharmacol. Exp. Ther. 327, 716-726.
18. Ng, Y., Goldspink, D. F., Burniston, J. G., Clark, W. A., Colyer, J., and Tan, L.-B. (2002). Characterization of isoprenaline myotoxicity on slow-twitch skeletal versus cardiac muscle. Int. J. Cardiol. 86 (2-3), 299-309.
19. O'Brien, P. J., Smith, D. E. C., Knechtel, T. J., Marchak, M. A., Pruimboom-Brees, I., Brees, D. J., Spratt, D. P., Archer, F. J., Butler, P., Potter, A. N., et al. (2006). Cardiac troponin I is a sensitive, specific biomarker of cardiac injury in laboratory animals. Lab. Anim. 40, 153-171.
20. Pritt, M. L., Hall, D. G., Recknor, J., Credille, K. M., Brown, D. D., Yumibe, N. P., Schultze, A. E., and Watson, D. E. (2008). Fabp3 as a biomarker of skeletal muscle toxicity in the rat: Comparison with conventional biomarkers. Toxicol. Sci. 103, 382-396.
21. Schaefer, W. H., Lawrence, J. W., Loughlin, A. F., Stoffregen, D. A., Mixson, L. A., Dean, D. C., Raab, C. E., Yu, N. X., Lankas, G. R., and Frederick, C. B. (2004). Evaluation of ubiquinone concentration and mitochondrial function relative to cerivastatin-induced skeletal myopathy in rats. Toxicol. Appl. Pharmacol. 194, 10-23.
22. Seachrist, J. L., Loi, C.-M., Evans, M. G., Criswell, K. A., and Rothwell, C. E. (2005). Roles of exercise and pharmacokinetics in cerivastatin-induced skeletal muscle injury. Toxicol. Sci. 88 551-561.
23. Semenova, L. A., Martyniuk, R. A., and Martsinovich, V. P. (1975). Acute lesion of rat myocardium by a single injection of cobalt dichloride. Cor Vasa. 17, 145-150.
24. Simpson, J. A., Labugger, R., Collier, C., Brison, R. J., Iscoe, S., and Van Eyk, J. E. (2005). Fast and slow skeletal troponin I in serum from patients with various skeletal muscle disorders: A pilot study. Clin. Chem. 51, 966-972.
25. Simpson, J. A., Van Eyk, J., and Iscoe, S. (2004). Respiratory muscle injury, fatigue and serum skeletal troponin I in rat. J. Physiol. 554, 891-903.
26. Sorichter, S., Mair, J., Koller, A., Calzolari, C., Huonker, M., Pau, B., and Puschendorf, B. (2001). Release of muscle proteins after downhill running in male and female subjects. Scand. J. Med. Sci. Sports 11, 28-32.
27. Sorichter, S., Mair, J., Koller, A., Gebert, W., Rama, D., Calzolari, C., Artner-Dworzak, E., and Puschendorf, B. (1997). Skeletal troponin I as a marker of exercise-induced muscle damage. J. Appl. Physiol. 83, 1076-1082.
28. Sorichter, S., Puschendorf, B., and Mair, J. (1999). Skeletal muscle injury induced by eccentric muscle action: Muscle proteins as markers of muscle fiber injury. Exerc. Immunol. Rev. 5, 5-21.
29. 3-adrenoreceptor antagonists. Br. J. Pharmacol. 142, 667-670.
30. Takahashi, M., Lee, L., Shi, Q., Gawad, Y., and Jackowski, G. (1996). Use of enzyme immunoassay for measurement of skeletal troponin-I utilizing isoform-specific monoclonal antibodies. Clin. Biochem. 29, 301-308.
31. Thompson, P. D., Clarkson, and Karas, R. H. (2003). Statin-associated myopathy. JAMA 289, 1681-1690.
32. Vanholder, R., Sukru Sever, M., Erek, E., and Lameire, N. (2000). Rhabdomyolysis. J. Am. Soc. Nephrol. 11, 1553-1561.
33. Westwood, F. R., Bigley, A., Randall, K., Marsden, A. M., and Scott, R. C. (2005). Statin-induced muscle necrosis in the rat: Distribution, development, and fibre selectivity. Toxicol. Pathol. 33, 246-257.
34. Wilkinson, J. M., and Grand, J. A. (1978). Comparison of amino acid sequence of troponin I from different striated muscles. Nature 271, 31-35.